Skip to content

Pro-social Power Training Activity for Aging and Well-being With Chronic Kidney Disease

Activation for Self-Care Needs in Older Adults With Chronic Kidney Disease: ACTIVE SENIORS With CKD

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06089057
Enrollment
30
Registered
2023-10-18
Start date
2026-07-15
Completion date
2029-09-01
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Extremity Muscle Strength

Keywords

mobility

Brief summary

This is a pilot trial of a 16-week physical activity and power training program among up to 30 Veterans/arm with advanced chronic kidney disease. The trial aims to test whether the program is tolerable to Veterans.

Detailed description

This will be a randomized controlled pilot trial of a 16-week physical activity and power training intervention trial among up to 30 pre-frail Veterans with Stage 3B-5 chronic kidney disease. The intervention will contain in-center and at-home components. It will lay the foundation for a large-scale future randomized controlled efficacy trial aimed to reduce frailty risk among Veterans with advanced chronic kidney disease. Up to 30 other Veterans will be part of an attention control. The outcomes of this pilot trial are feasibility, acceptability, and fidelity. Each of these outcomes will be measured using quantitative surveys and data review as well as qualitative assessments among Veterans at trial close. As this is a pilot feasibility trial, it is intentionally not powered to detect whether the intervention has a significant effect on physical activity frequency, muscle strength, or physical frailty.

Interventions

BEHAVIORALAttention Control for Pro-social Power training Activity for Aging and Well-being with Chronic Kidney Disease

This will be the attention control arm that will involve receipt of a physical activity education booklet, use of an accelerometer, and weekly check-in calls. No power training or motivational coaching will be delivered.

BEHAVIORALPro-social Power training Activity for Aging and Well-being with Chronic Kidney Disease

This is a 16-week power-training and physical activity-focused intervention that contains group in-center and individual at-home components and motivational coaching. Participants will meet 2-3 times per week for the in-center power training. Participants will also be asked to wear accelerometers at home in order for their physical activity frequency to be measured.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Masking description

All research assistants and biostatistics personnel will be masked to each participant's assignment. Participants and study staff are unaware of group allocation at the time of recruitment and baseline assessments because randomization is performed after participants have completed baseline assessments. However, there is no blinding to group allocation after randomization.

Intervention model description

Veterans will be randomized to either the intervention to an attention control. Randomization will be performed by the biostatistician. Veterans will be randomized to the intervention group (or to the attention control) using a block randomization scheme with randomly selected block sizes of 2, 4, and 6. Participants in the attention control will receive educational resources regarding the benefits of physical activity prior to intervention start (A brief document related to the importance of physical activity in kidney disease and handouts from the Center for Disease Control's recommendations for physical activity for older adults). Participants in the attention control may also receive a weekly phone call on general health.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Participant's nephrologist and/or primary care physician agree that participant may enroll in trial * Participants classified as pre-frail per Fried Frailty phenotype due to slowness (time taken to walk 15 feet is greater than 6 seconds) in Aim 1, OR who report 'YES' to any of the following: * "For health or physical reasons, do you have difficulty in walking a mile (5-6 blocks)?", OR * "If no, have you changed the way you walk half a mile (5-6 blocks) because of underlying health problems?", OR * "For health or physical reasons, do you have difficulty in climbing 1 flight of stairs (10 steps)?", OR * "If no, have you changed the way you climb 1 flight of stairs (10 steps) because of health problems?"

Exclusion criteria

* Myocardial infarction or unstable angina within the prior six months based on electronic medical record review or self-report * Uncontrolled cardiac arrythmia within the prior six months based on electronic medical record review or self-report * Systolic blood pressure \> 180 mm Hg and/or diastolic blood pressure \> 110 mm Hg on more than one occasion within prior six months based on electronic medical record review or self-report * Cerebrovascular event and/or transient ischemic attack within prior six months based on electronic medical record review or self-report * Abnormal cardiac stress test within the past year based on electronic medical record review or self-report * Hemoglobin of 10 g/dL or less based on electronic medical record review or self-report * Class IV heart failure based on electronic medical record review or self-report * Dyspnea and/or chest pain at rest * Dependence on wheelchair for mobility * Permanent residence in nursing home or other long-term care facility * Terminal illness or other hospice-qualifying medical condition * Planned move away from middle Tennessee within the next year * Planned major surgery in the next six months * Blindness * Concurrent enrollment in physical therapy or structured exercise program * Anticipated dialysis or kidney transplant in upcoming three months * Non-English speaking * Severe cognitive impairment based on electronic medical record review or self-report

Design outcomes

Primary

MeasureTime frameDescription
Feasibility, as measured by the questionnaire, the Feasibility of Intervention Measure4 monthsThis will be a brief questionnaire known as the Feasibility of Intervention Measure, that asks participants whether the intervention seems doable to them. There are four questions, and participants are asked to rate intervention feasibility from a scale of 1 (Strongly Disagree) to 5 (Strongly Agree). Scores range from 1-5 and are calculated as the mean of all scores. Higher scores indicate greater perceived feasibility. This will not be aggregated with any other measure.
Feasibility, as measured by a numerical percentage of all participants who consented out of those eligible4 monthsThis will be a numeric percentage of participants who consent for the pilot trial out of all eligible participants in Aim 1. This will not be aggregated with any other measure.
Feasibility, as measured by a qualitative description of participants' reasons for declining4 monthsThis will be a qualitative description of potential participants' reasons for declining, if applicable. This will not be aggregated with any other measure.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDevika Nair, MD

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026